Posted by Michael Wonder on 11 Mar 2025
ICER to assess treatment for non-cystic fibrosis bronchiectasis
11 March 2025 - Report will be subject of CTAF meeting in September 2025; draft scoping document open to public comment until 31 March 2025
The ICER announced today that it will assess the comparative clinical effectiveness and value of brensocatib (Insmed) for the treatment of non-cystic fibrosis bronchiectasis.
